MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2
Background/Aims: MiR-26a has been identified as a tumor suppressor in various tumors, but the relationship between miR-26a and the sensitivity of gastric cancer to chemotherapies has not been established. The present study was performed to investigate the effect of miR-26a on drug sensitivity in gas...
Main Authors: | Lan Wen, Fangzhi Cheng, Yanyan Zhou, Chunhua Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2015;volume=21;issue=5;spage=313;epage=319;aulast=Wen |
Similar Items
-
Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis
by: Michio Ozeki, et al.
Published: (2019-09-01) -
M-RAS Regulate CDH1 Function in Blastomere Compaction during Porcine Embryonic Development
by: Dongjie Zhou, et al.
Published: (2020-03-01) -
Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives
by: Renata Tisi, et al.
Published: (2020-11-01) -
A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma
by: Vid Mlakar, et al.
Published: (2021-06-01) -
Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor
by: Hirofumi Yoshino, et al.
Published: (2023-06-01)